Use of Third Line Antiretroviral Therapy in Latin America

BACKGROUND: Access to highly active antiretroviral therapy (HAART) is expanding in Latin America. Many patients require second and third line therapy due to toxicity, tolerability, failure, or a combination of factors. The need for third line HAART, essential for program planning, is not known. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Cesar, Carina, Shepherd, Bryan E., Jenkins, Cathy A., Ghidinelli, Massimo, Castro, Jose Luis, Veloso, Valdiléa Gonçalves, Cortes, Claudia P., Padgett, Denis, Crabtree-Ramirez, Brenda, Gotuzzo, Eduardo, Fink, Valeria, Duran, Adriana, Sued, Omar, McGowan, Catherine C., Cahn, Pedro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164470/
https://www.ncbi.nlm.nih.gov/pubmed/25221931
http://dx.doi.org/10.1371/journal.pone.0106887

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164470/
https://www.ncbi.nlm.nih.gov/pubmed/25221931
http://dx.doi.org/10.1371/journal.pone.0106887

Ejemplares similares